Journal of Infection, 2024 Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals Quek A., Wang S., Teng O. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Frontiers in Neurology, 2024 Role of inflammatory biomarkers in mediating the effect of lipids on spontaneous intracerebral hemorrhage: a two-step, two-sample Mendelian randomization study Huang M., Liu Y., Cheng Y. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Nature Communications, 2024 Deciphering the genetics and mechanisms of predisposition to multiple myeloma Went M., Duran-Lozano L., Halldorsson G. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Cardio-Oncology, 2024 Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF van den Berg P., Yousif L., Markousis-Mavrogenis G. et al. Olink Target 96OncologyCVDPathophysiologyPatient StratificationPlasma | | | | |
Journal of Proteome Research, 2024 Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank Cao J., Zhuang M., Kong H. et al. Olink Explore 3072/384OphthalmologyPathophysiologyPlasma | | | | |
Journal of Allergy and Clinical Immunology, 2024 Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma Howell I., Yang F., Brown V. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasmaSputum | | | | |
Cancer Science, 2024 Multiplex plasma protein assays as a diagnostic tool for lung cancer Ahamed M., Forshed J., Levitsky A. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Nature Communications, 2024 Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s disease Doostparast Torshizi A., Truong D., Hou L. et al. Olink Explore 3072/384NeurologyPathophysiologyPlasma | | | | |
European Journal of Heart Failure, 2024 Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial Tromp J., Lam C., Alemayehu W. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
eClinicalMedicine, 2024 Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial Weng L., Wei L., Zhang Q. et al. Olink Target 96ObstetricsPathophysiologyPlasma | | | | |
Pediatric Obesity, 2024 Neurological‐related proteomic profiling in plasma of children with metabolic healthy and unhealthy overweight/obesity Olvera‐Rojas M., Plaza‐Florido A., Solis‐Urra P. et al. Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma | | | | |
Cardiovascular Research, 2024 Coronavirus disease 2019–related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities Ćorović A., Zhao X., Huang Y. et al. Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologySerum | | | | |
CNS Neuroscience & Therapeutics, 2024 Shared genetics and causal association between plasma levels of SARS‐CoV‐2 entry receptor ACE2 and Alzheimer's disease Zhang Y., Xu F., Wang T. et al. Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma | | | | |
Journal for ImmunoTherapy of Cancer, 2024 Immune cell topography of head and neck cancer Muijlwijk T., Nijenhuis D., Ganzevles S. et al. Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium | | | | |
Heliyon, 2024 Causal relationships between immune cells, inflammatory factors, serum metabolites, and hepatic cancer: A two-sample Mendelian randomization study Chen H., Yang R., Zhang J. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024 Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms Villikudathil A., Mc Guigan D., English A. Olink Target 96Metabolic DiseasesPatient StratificationData SciencePlasma | | | | |
Diabetes Care, 2024 Large-Scale Proteomics Improve Prediction of Chronic Kidney Disease in People With Diabetes Ye Z., Zhang Y., Zhang Y. et al. Olink Explore 3072/384NephrologyPatient StratificationPlasma | | | | |
Nature Medicine, 2024 Proteomic signatures improve risk prediction for common and rare diseases Carrasco-Zanini J., Pietzner M., Davitte J. et al. Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma | | | | |
Journal of Proteome Research, 2024 Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression Yu S., Yang L., Shu J. et al. Olink Target 96OncologyPathophysiologyPatient StratificationTissue Lysate | | | | |
Archives of Dermatological Research, 2024 Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo Yamaguchi Y., Peeva E., Duca E. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum | | | | |